TG Therapeutics, Inc. (TGTX)
64.48
-0.08
(-0.12%)
USD |
NASDAQ |
Nov 13, 16:00
64.48
0.00 (0.00%)
After-Hours: 19:59
TG Therapeutics Market Cap : 9.747B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 9.759B |
| November 11, 2026 | 9.940B |
| November 10, 2026 | 9.714B |
| November 09, 2026 | 9.580B |
| November 06, 2026 | 9.043B |
| November 05, 2026 | 8.764B |
| November 04, 2026 | 9.434B |
| November 03, 2026 | 9.299B |
| November 02, 2026 | 9.177B |
| October 30, 2026 | 9.365B |
| October 29, 2026 | 8.891B |
| October 28, 2026 | 8.787B |
| October 27, 2026 | 8.640B |
| October 26, 2026 | 8.387B |
| October 23, 2026 | 8.292B |
| October 22, 2026 | 8.138B |
| October 21, 2026 | 8.144B |
| October 20, 2026 | 8.347B |
| October 19, 2026 | 8.159B |
| October 16, 2026 | 8.262B |
| October 15, 2026 | 8.572B |
| October 14, 2026 | 8.323B |
| October 13, 2026 | 8.318B |
| October 12, 2026 | 8.461B |
| October 09, 2026 | 8.476B |
| Date | Value |
|---|---|
| October 08, 2026 | 8.165B |
| October 07, 2026 | 8.105B |
| October 06, 2026 | 7.989B |
| October 05, 2026 | 8.252B |
| October 02, 2026 | 8.311B |
| October 01, 2026 | 8.208B |
| September 30, 2026 | 8.539B |
| September 29, 2026 | 8.601B |
| September 28, 2026 | 8.601B |
| September 25, 2026 | 8.791B |
| September 24, 2026 | 8.805B |
| September 23, 2026 | 8.572B |
| September 22, 2026 | 8.895B |
| September 21, 2026 | 8.750B |
| September 18, 2026 | 8.706B |
| September 17, 2026 | 8.644B |
| September 16, 2026 | 8.549B |
| September 15, 2026 | 8.119B |
| September 14, 2026 | 8.266B |
| September 11, 2026 | 8.249B |
| September 10, 2026 | 8.479B |
| September 09, 2026 | 8.366B |
| September 08, 2026 | 8.533B |
| September 04, 2026 | 8.570B |
| September 03, 2026 | 8.681B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amneal Pharmaceuticals, Inc. | 7.446B |
| Vertex Pharmaceuticals, Inc. | 136.55B |
| Regeneron Pharmaceuticals, Inc. | 98.78B |
| SELLAS Life Sciences Group, Inc. | 1.589B |
| Travere Therapeutics, Inc. | 4.848B |
Market Cap Related Metrics
| PE Ratio | 95.75 |
| PS Ratio | 11.36 |
| Price to Book Value | 17.04 |
| Price to Free Cash Flow | 119.19 |
| Price | 64.48 |
| Earnings Yield | 1.04% |
| Operating PE Ratio | 52.88 |
| Normalized PE Ratio | 89.41 |